Physician profile
Annika Chadee
NPI 1942549134
$1,381.58
in general payments reported to CMS, 2019-2025
21 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.86 · 2021: $311 · 2022: $267 · 2023: $337 · 2024: $252 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.68 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $304.02 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $178.66 | 2021-2023 | Lo Loestrin Fe, Orilissa |
| Myovant Sciences INC. | $127.05 | 2021 | |
| Intuitive Surgical, INC. | $97.67 | 2022 | |
| Hologic Sales and Service, LLC | $82.71 | 2024-2025 | Acessa Provu System, Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Axonics, INC. | $66.83 | 2022 | |
| Exeltis, USA INC. | $59.23 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $58.22 | 2022-2023 | |
| Millicent US INC | $48.15 | 2024-2025 | Intrarosa |
| Sumitomo Pharma America, INC. | $44.89 | 2023 | Myfembree |
| Therapeuticsmd, INC. | $41.24 | 2021-2022 | |
| Coopersurgical, INC. | $38.03 | 2023-2025 | Mara Console, Paragard T 380a |
| Optumhealth Care Solutions, LLC | $35.79 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coloplast Corp | $35.72 | 2021 | |
| Pfizer INC. | $29.27 | 2021-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mycovia Pharmaceuticals, INC. | $26.78 | 2023 | Vivjoa |
| Bayer Healthcare Pharmaceuticals INC. | $24.81 | 2023 | |
| Allergan, INC. | $23.86 | 2020 | |
| Renovia INC | $22.46 | 2021 | |
| Medtronic, INC. | $22.09 | 2023 | Truclear |
| Ascend Therapeutics US, LLC | $14.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annika Chadee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.